23andMe Gets $115M From Fidelity, Others
Mountain View-based genetics analysis developer 23andMe says this morning that it has raised a big, $115M Series E funding round, led by Fidelity Management & Research Company. The funding also included Casdin Capital, WuXi Healthcare Ventures and Xfund, plus Illumina, New Enterprise Associates, MPM Capital, and Google Ventures. 23andMe said the funding goes towards expanding its operations, plus new laboratory space, a sequencing laboratory, and more.
posted on Wednesday, October 14, 2015 (Link to more information)
Related companies:
23andMe
Related stories:
> 23andMe Gets $250M For DNA Testing Efforts
> 23andMe Gets $300M From GlaxoSmithKline
> 23andMe Buys CureTogether
> Google Puts $3.9M In 23andMe
> 23andMe Decodes Another $50M
silicontap.com Home